Additional Treatment for Digital Ulcers in Patients with Systemic Sclerosis: A Prospective, Open-Label, Multi-Arm Study for the use of Platelet-Rich Plasma-Lipofilling and Ultrasound-Based Treatments

R. Pirrello, C. Schinocca, D. Scaturro, C. Rizzo, Pietro Terrana, L. Tumminelli, P. Ruscitti, A. Cordova, R. Giacomelli, F. Ciccia, G. Mauro, G. Guggino
{"title":"Additional Treatment for Digital Ulcers in Patients with Systemic Sclerosis: A Prospective, Open-Label, Multi-Arm Study for the use of Platelet-Rich Plasma-Lipofilling and Ultrasound-Based Treatments","authors":"R. Pirrello, C. Schinocca, D. Scaturro, C. Rizzo, Pietro Terrana, L. Tumminelli, P. Ruscitti, A. Cordova, R. Giacomelli, F. Ciccia, G. Mauro, G. Guggino","doi":"10.21203/rs.3.rs-138437/v1","DOIUrl":null,"url":null,"abstract":"\n Background: Local treatments such as ultraviolet-A (UVA) phototherapy, topical calcitriol, injection of autologous fat grafting, Platelet-Rich Plasma (PRP), hyaluronic acid (HA) and local ultrasound (US) treatment are considered alternative approaches for skin involvement in Systemic sclerosis (SSc).The aim of our study was to evaluate the efficacy of PRP injection and lipofilling or local ultrasound in the treatment of SSc-related digital ulcers (DUs). Methods: We enrolled 28 patients with SSc. At baseline time (T0), all patients were treated with Iloprost intravenous infusions. Then, six patients (group 1) received a first inoculation of PRP, after 15 days a second inoculation of PRP and after 15 days a third of lipofilling. Other six patients (group 2) received the three consecutive injections associated with a maintenance therapy with additional injections of PRP every 30 days for 12 months. Six patients continued only the Iloprost therapy (controls). Ten patients (group 3) underwent medical sessions with ultrasound treatment for 10 days. Clinical evaluation was assessed at baseline, after 3 and 12 months of treatment for all patients.Results: In our study have shown an improvement in cutaneous and microvascular level, in quality of life, in mobility of extremities of upper limbs and a reduction of administration of Iloprost after PRP-Lipofilling and US treatment.Conclusions: Our findings suggest that PRP, coupled with lipofilling, and ultrasound treatment in SSc patients, can be considered additional procedures in the management of DUs.","PeriodicalId":15066,"journal":{"name":"Journal of Biotechnology and Biomedicine","volume":"104 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biotechnology and Biomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21203/rs.3.rs-138437/v1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Local treatments such as ultraviolet-A (UVA) phototherapy, topical calcitriol, injection of autologous fat grafting, Platelet-Rich Plasma (PRP), hyaluronic acid (HA) and local ultrasound (US) treatment are considered alternative approaches for skin involvement in Systemic sclerosis (SSc).The aim of our study was to evaluate the efficacy of PRP injection and lipofilling or local ultrasound in the treatment of SSc-related digital ulcers (DUs). Methods: We enrolled 28 patients with SSc. At baseline time (T0), all patients were treated with Iloprost intravenous infusions. Then, six patients (group 1) received a first inoculation of PRP, after 15 days a second inoculation of PRP and after 15 days a third of lipofilling. Other six patients (group 2) received the three consecutive injections associated with a maintenance therapy with additional injections of PRP every 30 days for 12 months. Six patients continued only the Iloprost therapy (controls). Ten patients (group 3) underwent medical sessions with ultrasound treatment for 10 days. Clinical evaluation was assessed at baseline, after 3 and 12 months of treatment for all patients.Results: In our study have shown an improvement in cutaneous and microvascular level, in quality of life, in mobility of extremities of upper limbs and a reduction of administration of Iloprost after PRP-Lipofilling and US treatment.Conclusions: Our findings suggest that PRP, coupled with lipofilling, and ultrasound treatment in SSc patients, can be considered additional procedures in the management of DUs.
系统性硬化症患者数字溃疡的额外治疗:一项前瞻性,开放标签,多组研究,使用富血小板血浆脂填充和超声治疗
背景:局部治疗如紫外线a (UVA)光疗、局部骨化三醇、注射自体脂肪移植、富血小板血浆(PRP)、透明质酸(HA)和局部超声(US)治疗被认为是治疗皮肤受损伤系统性硬化症(SSc)的替代方法。我们的研究目的是评估PRP注射和脂质填充或局部超声治疗ssc相关性手指溃疡(DUs)的疗效。方法:我们纳入28例SSc患者。在基线时间(T0),所有患者接受依洛前列素静脉输注治疗。然后,6例患者(1组)接受第一次PRP接种,15天后第二次PRP接种,15天后第三次脂质填充。另外6名患者(第二组)接受3次连续注射,同时进行维持治疗,每30天额外注射PRP,持续12个月。6例患者仅接受依洛前列素治疗(对照组)。10例患者(第三组)接受10天的超声治疗。在基线、治疗3个月和12个月后对所有患者进行临床评估。结果:在我们的研究中显示,在prp -脂质填充和US治疗后,皮肤和微血管水平、生活质量、上肢肢的活动能力和伊洛前列素的使用减少。结论:我们的研究结果表明,PRP,再加上脂质填充和超声治疗SSc患者,可以被认为是管理du的附加程序。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信